Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1650
| Despition | HSPB8 Human Recombinant |
| SIZE | 2 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1151 | Recombinant HuD Protein (AC1151) | 10 µg | inquiry |
| ACPP-1651 | Human AIDA Protein (AC1651) | 2 µg | inquiry |
| ACPP-1634 | NDK E.Coli (AC1634) | 5 µg | inquiry |
| ACPP-1137 | Recombinant HuD Antigen (AC1137) | 100 µg | inquiry |
| ACPP-1510 | Human TIMP1 Protein, Sf9 (AC1510) | 2 µg | inquiry |
| ACPP-1359 | iNOS Blocking Peptide (AC1359) | 250 µg | inquiry |
| ACPP-1470 | Human CLTA Protein (AC1470) | 5 µg | inquiry |
| ACPP-1539 | Human Acrp30 (108-244) Protein (AC1539) | 5 µg | inquiry |
| ACPP-1659 | Human Visfatin Protein (AC1659) | 5 µg | inquiry |
| ACPP-1812 | Human IMPA1 Protein (AC1812) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.